메뉴 건너뛰기




Volumn 304, Issue 10, 2010, Pages 1082-1090

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: A randomized controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LOPINAVIR; PROTEINASE INHIBITOR; PYRIMIDINONE DERIVATIVE;

EID: 77956410563     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1278     Document Type: Article
Times cited : (72)

References (39)
  • 1
    • 35548942272 scopus 로고    scopus 로고
    • Prevalence of resistance to nevirapine in mothers and children after singledose exposure to prevent vertical transmission of HIV-1: A meta-analysis
    • Ghent Group on HIV in Women and Children
    • Arrivé E, Newell ML, Ekouevi DK, et al; Ghent Group on HIV in Women and Children. Prevalence of resistance to nevirapine in mothers and children after singledose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007;36(5):1009-1021.
    • (2007) Int J Epidemiol , vol.36 , Issue.5 , pp. 1009-1021
    • Arrivé, E.1    Newell, M.L.2    Ekouevi, D.K.3
  • 2
    • 33847169926 scopus 로고    scopus 로고
    • Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine
    • Martinson NA, Morris L, Gray G, et al. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2007;44(2):148-153.
    • (2007) J Acquir Immune Defic Syndr , vol.44 , Issue.2 , pp. 148-153
    • Martinson, N.A.1    Morris, L.2    Gray, G.3
  • 3
    • 33846156885 scopus 로고    scopus 로고
    • Response to antiretroviral therapy after a single, peripartum dose of nevirapine
    • Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med. 2007; 356(2):135-147.
    • (2007) N Engl J Med , vol.356 , Issue.2 , pp. 135-147
    • Lockman, S.1    Shapiro, R.L.2    Smeaton, L.M.3
  • 5
    • 77649123118 scopus 로고    scopus 로고
    • Lopinavir /ritonavir+tenofovir/emtricitabine is superior to nevirapine+tenofovir/emtricitabine for women with prior exposure to single-dose nevirapine
    • A5208/OCTANE Study Team.
    • Lockman S; A5208/OCTANE Study Team. Lopinavir /ritonavir+tenofovir/ emtricitabine is superior to nevirapine+tenofovir/emtricitabine for women with prior exposure to single-dose nevirapine. 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.
    • 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada
    • Lockman, S.1
  • 7
    • 51949105562 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: A prospective cohort study
    • Davies MA, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008;8:34.
    • (2008) BMC Pediatr , vol.8 , pp. 34
    • Davies, M.A.1    Boulle, A.2    Fakir, T.3    Nuttall, J.4    Eley, B.5
  • 8
    • 34249888233 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management
    • DOI 10.1542/peds.2006-1232
    • Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119(6):e1371-e1383. (Pubitemid 46871324)
    • (2007) Pediatrics , vol.119 , Issue.6
    • Simoni, J.M.1    Montgomery, A.2    Martin, E.3    New, M.4    Demas, P.A.5    Rana, S.6
  • 9
    • 41149107340 scopus 로고    scopus 로고
    • Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis
    • Ren Y, Nuttall JJ, Egbers C, et al. Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2008;47(5):566-569.
    • (2008) J Acquir Immune Defic Syndr , vol.47 , Issue.5 , pp. 566-569
    • Ren, Y.1    Nuttall, J.J.2    Egbers, C.3
  • 10
    • 4444315072 scopus 로고    scopus 로고
    • Metabolic complications of HIV therapy in children
    • DOI 10.1097/00002030-200409030-00004
    • McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18 (13):1753-1768. (Pubitemid 39179627)
    • (2004) AIDS , vol.18 , Issue.13 , pp. 1753-1768
    • McComsey, G.A.1    Leonard, E.2
  • 11
    • 0037999058 scopus 로고    scopus 로고
    • Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children
    • Bitnun A, Sochett E, Babyn P, et al. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children. AIDS. 2003;17(9):1319-1327.
    • (2003) AIDS , vol.17 , Issue.9 , pp. 1319-1327
    • Bitnun, A.1    Sochett, E.2    Babyn, P.3
  • 12
    • 15044343044 scopus 로고    scopus 로고
    • Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C
    • Pediatric AIDS Clinical Trials Group Study 219C Team
    • Farley J, Gona P, Crain M, et al; Pediatric AIDS Clinical Trials Group Study 219C Team. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr. 2005;38(4):480-487.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , Issue.4 , pp. 480-487
    • Farley, J.1    Gona, P.2    Crain, M.3
  • 13
    • 67651083739 scopus 로고    scopus 로고
    • Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy
    • Smith K, Kuhn L, Coovadia A, et al. Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy. AIDS. 2009;23(9):1097-1107.
    • (2009) AIDS , vol.23 , Issue.9 , pp. 1097-1107
    • Smith, K.1    Kuhn, L.2    Coovadia, A.3
  • 14
    • 77950190296 scopus 로고    scopus 로고
    • Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: Effect of cotreatment for tuberculosis
    • Reitz C, Coovadia A, Ko S, et al. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis. 2010;201(8):1121-1131.
    • (2010) J Infect Dis , vol.201 , Issue.8 , pp. 1121-1131
    • Reitz, C.1    Coovadia, A.2    Ko, S.3
  • 17
    • 33748642352 scopus 로고    scopus 로고
    • Less than 95% adherence to non-nucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression
    • Bangsberg DR. Less than 95% adherence to non-nucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43(7):939-941.
    • (2006) Clin Infect Dis , vol.43 , Issue.7 , pp. 939-941
    • Bangsberg, D.R.1
  • 18
    • 45749155787 scopus 로고    scopus 로고
    • Antiretroviral drug resistance surveillance among drug-naive HIV- 1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
    • Pillay V, Ledwaba J, Hunt G, et al. Antiretroviral drug resistance surveillance among drug-naive HIV- 1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir Ther. 2008;13(suppl 2): 101-107.
    • (2008) Antivir Ther , vol.13 , Issue.SUPPL. 2 , pp. 101-107
    • Pillay, V.1    Ledwaba, J.2    Hunt, G.3
  • 19
    • 77956835429 scopus 로고    scopus 로고
    • Development of drug resistance among a cohort of HIV-infected infants exposed to nevirapine for prevention of mother-to-child transmission initiating PI-based ART in South Africa
    • [abstract 957]
    • Hunt G, Taylor B, Coovadia A, et al. Development of drug resistance among a cohort of HIV-infected infants exposed to nevirapine for prevention of mother-to-child transmission initiating PI-based ART in South Africa [abstract 957]. 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.
    • 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada
    • Hunt, G.1    Taylor, B.2    Coovadia, A.3
  • 20
    • 77956806036 scopus 로고    scopus 로고
    • Plasma frequencies of nevirapine resistance influence virologic responses to nevirapine maintenance therapy in single-dose exposed HIV-infected children initially treated with lopinavir HAART
    • [abstract 159]
    • Moorthy A, Kuhn L, Coovadia A, et al. Plasma frequencies of nevirapine resistance influence virologic responses to nevirapine maintenance therapy in single-dose exposed HIV-infected children initially treated with lopinavir HAART [abstract 159]. 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA.
    • 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA
    • Moorthy, A.1    Kuhn, L.2    Coovadia, A.3
  • 21
    • 48949097660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
    • International AIDS Society-USA.
    • Hammer SM, Eron JJ Jr, Reiss P, et al; International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008; 300(5):555-570.
    • (2008) JAMA , vol.300 , Issue.5 , pp. 555-570
    • Hammer, S.M.1    Eron Jr., J.J.2    Reiss, P.3
  • 24
    • 1642294551 scopus 로고    scopus 로고
    • Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients
    • Bucher HC, Kofler A, Nüesch R, Young J, Battegay M, Opravil M. Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients. AIDS. 2003;17(17):2451-2459.
    • (2003) AIDS , vol.17 , Issue.17 , pp. 2451-2459
    • Bucher, H.C.1    Kofler, A.2    Nüesch, R.3    Young, J.4    Battegay, M.5    Opravil, M.6
  • 25
    • 0036258816 scopus 로고    scopus 로고
    • Switch studies: A review
    • Murphy RL, Smith WJ. Switch studies: a review. HIV Med. 2002;3(2):146-155.
    • (2002) HIV Med , vol.3 , Issue.2 , pp. 146-155
    • Murphy, R.L.1    Smith, W.J.2
  • 26
    • 33748042284 scopus 로고    scopus 로고
    • Benefits and concerns of simplification strategies in HIV-infected patients
    • DOI 10.1093/jac/dkl191
    • Negredo E, Bonjoch A, Clotet B. Benefits and concerns of simplification strategies in HIV-infected patients. J Antimicrob Chemother. 2006;58(2): 235-242. (Pubitemid 44294932)
    • (2006) Journal of Antimicrobial Chemotherapy , vol.58 , Issue.2 , pp. 235-242
    • Negredo, E.1    Bonjoch, A.2    Clotet, B.3
  • 27
    • 54049090424 scopus 로고    scopus 로고
    • Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: A meta-analysis of randomized controlled trials
    • Ena J, Leach A, Nguyen P. Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials. HIV Med. 2008;9(9): 747-756.
    • (2008) HIV Med , vol.9 , Issue.9 , pp. 747-756
    • Ena, J.1    Leach, A.2    Nguyen, P.3
  • 28
    • 0042387870 scopus 로고    scopus 로고
    • Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
    • Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team.
    • Martínez E, Arnaiz JA, Podzamczer D, et al; Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med. 2003; 349(11):1036-1046.
    • (2003) N Engl J Med , vol.349 , Issue.11 , pp. 1036-1046
    • Martínez, E.1    Arnaiz, J.A.2    Podzamczer, D.3
  • 29
    • 0034458546 scopus 로고    scopus 로고
    • Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA
    • Raffi F, Bonnet B, Ferré V, et al. Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA. Clin Infect Dis. 2000;31(5):1274-1278.
    • (2000) Clin Infect Dis , vol.31 , Issue.5 , pp. 1274-1278
    • Raffi, F.1    Bonnet, B.2    Ferré, V.3
  • 30
    • 0035393524 scopus 로고    scopus 로고
    • Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study
    • Spanish Lipodystrophy Group
    • Ruiz L, Negredo E, Domingo P, et al; Spanish Lipodystrophy Group. Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study. J Acquir Immune Defic Syndr. 2001;27(3):229-236.
    • (2001) J Acquir Immune Defic Syndr , vol.27 , Issue.3 , pp. 229-236
    • Ruiz, L.1    Negredo, E.2    Domingo, P.3
  • 31
    • 0037082965 scopus 로고    scopus 로고
    • Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression
    • Negredo E, Cruz L, Paredes R, et al. Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. Clin Infect Dis. 2002; 34(4):504-510.
    • (2002) Clin Infect Dis , vol.34 , Issue.4 , pp. 504-510
    • Negredo, E.1    Cruz, L.2    Paredes, R.3
  • 32
    • 0038121117 scopus 로고    scopus 로고
    • First Pediatric Switch Study. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: Results of the First Pediatric Switch Study
    • McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A; First Pediatric Switch Study. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. Pediatrics. 2003;111(3):e275-e281.
    • (2003) Pediatrics , vol.111 , Issue.3
    • McComsey, G.1    Bhumbra, N.2    Ma, J.F.3    Rathore, M.4    Alvarez, A.5
  • 34
    • 34247552198 scopus 로고    scopus 로고
    • Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
    • Chi BH, Sinkala M, Stringer EM, et al. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS. 2007;21(8):957-964.
    • (2007) AIDS , vol.21 , Issue.8 , pp. 957-964
    • Chi, B.H.1    Sinkala, M.2    Stringer, E.M.3
  • 35
    • 58749088735 scopus 로고    scopus 로고
    • Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to non-nucleoside reverse-transcriptase inhibitor-based therapy
    • Coovadia A, Hunt G, Abrams EJ, et al. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to non-nucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis. 2009;48(4):462-472.
    • (2009) Clin Infect Dis , vol.48 , Issue.4 , pp. 462-472
    • Coovadia, A.1    Hunt, G.2    Abrams, E.J.3
  • 36
    • 69549103398 scopus 로고    scopus 로고
    • Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia
    • Kuhn L, Semrau K, Ramachandran S, et al. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009;52(1):132-136.
    • (2009) J Acquir Immune Defic Syndr , vol.52 , Issue.1 , pp. 132-136
    • Kuhn, L.1    Semrau, K.2    Ramachandran, S.3
  • 38
    • 56749097184 scopus 로고    scopus 로고
    • Early antiretroviral therapy and mortality among HIV-infected infants
    • CHER Study Team
    • Violari A, Cotton MF, Gibb DM, et al; CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359 (21):2233-2244.
    • (2008) N Engl J Med , vol.359 , Issue.21 , pp. 2233-2244
    • Violari, A.1    Cotton, M.F.2    Gibb, D.M.3
  • 39
    • 0003487632 scopus 로고    scopus 로고
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Accessed August 11, 2010
    • Guidelines for the use of antiretroviral agents in pediatric HIV infection. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. http://aidsinfo.nih.gov/contentFiles/PediatricGuidelines. pdf. Accessed August 11, 2010.
    • Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.